Editorial
 DRUG BAN POLICY   
 Wednesday, December 04, 2013 
 A leading financial daily reported last week that the Union health ministry is considering to disallow marketing of drugs in India which are already banned in two or more countries on grounds of efficacy and safety. 
  Past Editorial...  
TODAY'S NEWS
10:00  [IST]Biocartis teams up with VIB to develop unique diagnostic cancer test
09:00  [IST]Ashland to host AVANT Institute Winter 2013 symposium on 11th December at New Jersey
more news >>
TOP NEWS
08:00  [IST]Experts for inclusion of a South African model REC in CDA Bill for continuous monitoring of ECs
08:00  [IST]Govt sets up Central Council of Health & Family Welfare to recommend on policy matters on health
08:00  [IST]UDF urges creation of Ministry of Pharmaceuticals & Indian Pharmaceutical Services
08:00  [IST]Licensure for Indian Pharm D graduates in US a tedious and lengthy process: Dr Christine Birnie
08:00  [IST]State of Victoria’s Bionic Institute keen on tech-transfer of neuro bionics to NIMHANS, AIIMS
08:00  [IST]WHO's member-state mechanism on SSFFC medical products calls for strengthening of regulatory authorities
more news >>
YESTERDAY'S NEWS
16:00  [IST]US FDA grants orphan drug designation to Dyax's DX-2930 in hereditary angioedema
15:00  [IST]LabCentral inks pact with Life Technologies for technology suite of instruments
14:00  [IST]Mesoblast announces positive results from phase II trial of MPCs to treat type 2 diabetes
13:00  [IST]DSM, Tunitas Therapeutics ink agreement to develop new protein therapeutics of allergy
12:00  [IST]Eli Lilly phase III studies of edivoxetine as add-on therapy for MDD fails to meet primary endpoint
11:00  [IST]GSK forms OCT consortium with 6 renowned cancer research centres
more news >>
INTERVIEW  
South America an important market for Indian bio-pharma in future
Ajay Bharadwaj.jpgAjay Bharadwaj, CEO, Anthem Biosciences
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the newly introduced audio-visual recording of informed consent bring the much needed transparency in clinical trials in India?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |